PeptideStack
5.2kquestions
20kanswers
220users

What fraction of loss on semaglutide is lean mass according to SELECT?

Asked 9 Apr 2026Modified 14 days agoViewed 3.9k times
6

The case in front of me: semaglutide · SELECT.

The figures are clear enough; the question is what they mean and what they do not.

I can supply the numbers if the specifics change the answer.

How should I read this, and where are the traps?

lean-mass
lean-mass

Lean body mass as measured rather than assumed: what DEXA, BIA and air-displacement plethysmography each actually estimate, the body-composition…

164 questions
muscle-loss
muscle-loss

Loss of contractile tissue during energy deficit: what fraction of total loss is lean mass, why the commonly quoted figures are measurement…

82 questions
dexa
dexa

Dual-energy X-ray absorptiometry: what it measures, its precision limits, why hydration state and scan positioning move the numbers, and how to…

84 questions
shareeditfollowflag
DS
askedDr_Hanne_Solberg40k389 Apr 2026

5 Answers

Sorted by votes
34

Start with the arithmetic, because the answer to the practical question is usually a number and the number is usually achievable.

Hydration state moves a DEXA lean-mass figure directly, because the algorithm assigns water to the lean compartment. Scanning fasted, at the same time of day, before training and without a recent high-carbohydrate day is the difference between a comparable sequence and a noisy one. Bioelectrical impedance is far more sensitive to hydration again, which is why its trend is unusable at this timescale.

Put another way, cardio does not interfere with lean-mass retention at the volumes anyone here is doing; the interference effect in the literature appears at high concurrent volumes in trained athletes. What cardio does at a large deficit is add to the deficit, which is either the point or a problem depending on the objective.

The STEP 1 extension reported substantial regain in the year after treatment withdrawal, with weight and cardiometabolic variables trending back toward baseline[1].

The plateau is arithmetic. Treat it as arithmetic and the response follows.

shareimprove this answerflag
DW
answeredDr_Elias_Weiss46k388 Jul 2026
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
22

Put another way, the distinction that resolves this is between proportional loss and functional loss. Losing lean mass in proportion to total mass is what happens in every weight loss intervention. Losing function is not, and function is measurable.

Fibre at very low total intake is a trap. Soluble fibre needs water and motility to work; insoluble fibre adds bulk to a slow transit. At 900 kcal a day with delayed gastric emptying, an osmotic agent is more predictable than a bulking one, and adequate fluid is doing more work than either.

The first four weeks of loss is substantially fluid and glycogen. Each gram of stored glycogen carries roughly three grams of water, and total glycogen is on the order of 400 to 500 g, so the obligatory water shift alone accounts for a couple of kilograms. This is why the first month looks dramatic and the second looks like a plateau when in fact the fat-loss rate has not changed.

The body-composition substudies in the major programmes consistently report that the proportion of weight lost as fat mass is approximately three quarters or better, with the lean-mass fraction falling within the range seen in dietary weight loss of comparable magnitude[1].

One qualification: none of this is a clinical assessment, and unexplained loss of function rather than of mass is a reason to see someone rather than to adjust a programme.

A maintenance plan written before you need it is worth more than a better loss plan.

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven85k24811 Jul 2026
8Note that the label instructions differ between agents on precisely this point. – tyndall_haze 8 months ago
add a comment
16

In practice, the commonly quoted figures for lean-mass loss are mostly measurement artefacts, and the artefact is well understood: fat-free mass as measured includes water and glycogen, both of which fall early and neither of which is contractile tissue.

Absolute strength holds up better than scale weight during a deficit for a straightforward reason: strength is substantially neural and skill-based, and the contractile tissue you retain is being trained harder relative to its size. Grip strength and repetition maxima are therefore lagging indicators of muscle loss rather than leading ones, which is an argument for measuring both.

Specifically, the minimum effective resistance-training dose in a deficit is lower than most programmes assume. Two sessions a week covering the major movement patterns, with loads taken close to failure, is sufficient to retain most of what would otherwise be lost. Volume beyond that adds recovery cost that a large energy deficit is poorly placed to pay.

I would be careful with the supplement literature here; effect sizes are small, the studies are mostly in trained young men, and generalisation to a large deficit is not obviously valid.

Measure strength as well as mass. It is cheaper, it is less noisy, and it is closer to what you actually care about.

shareimprove this answerflag
MS
answeredmira_sundqvist19k182 Jul 2026
I would add a sentence about sterility here, since it is the thing people skip. – tobias_maartens 4 months ago
2The placebo-arm figure is the part everyone omits. – fill_volume 6 months ago
add a comment
13

The mechanism is worth having straight, because it predicts which interventions can work and which cannot.

Food noise returning is not obviously tolerance. Receptor desensitisation is one hypothesis; a second is that the initial effect was partly novelty and partly the steep early deficit, and a third is that intake has drifted upward and the signal is being outcompeted rather than weakened. The three make different predictions about what a dose increase would do.

Adaptive thermogenesis — a fall in energy expenditure beyond that predicted by the change in body composition — is documented across weight-loss interventions and is the mechanistic basis for the plateau being expected rather than anomalous.

Two resistance sessions a week and a protein target you actually hit will do more than any refinement beyond them.

edited 16 Jul 2026 by tandem_gradient — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
TG
answeredtandem_gradient85k24826 Jun 2026
Two of us worked through this independently and arrived here, so it is at least reproducible. – ekaterina_volk 7 months ago
8Worth adding that the method section is where the answer usually is. – j_wierzbicki 6 months ago
add a comment
13

What the data supports is narrower than what gets recommended, so it is worth separating the two.

Protein target, worked: at 88 kg, a target of 1.6 g/kg is 88 × 1.6 = 141 g per day. Spread across three eating occasions that is roughly 47 g each, and the leucine threshold for a maximal muscle protein synthetic response is met at around 2.5 to 3 g of leucine, which corresponds to roughly 30 to 40 g of a high-quality protein. So three meals at 40 g plus one 25 g snack gets you to 145 g and clears the per-meal threshold each time. On 900 kcal that leaves about 340 kcal for everything else, which is the actual constraint.

Train, eat the protein, measure something functional, and give the trend three months before you interpret it.

shareimprove this answerflag
HN
answeredhalvard_ness42k385 Jul 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.